Lenox Wealth Management’s GSK GSK Stock Holding History

Lenox Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$2K	Hold	52	–	–	﹤0.01%	640
2020 Q1	$2K	Sell	52 -117	-69%	-$6.24K	﹤0.01%	607
2019 Q4	$10K	Hold	169	–	–	﹤0.01%	445
2019 Q3	$9K	Hold	169	–	–	﹤0.01%	461
2019 Q2	$8K	Hold	169	–	–	﹤0.01%	455
2019 Q1	$9K	Buy	169 +28	+20%	+$1.4K	﹤0.01%	453
2018 Q4	$7K	Sell	141 -221	-61%	-$10.9K	﹤0.01%	432
2018 Q3	$18K	Buy	362 +169	+88%	+$8.59K	0.01%	341
2018 Q2	$10K	Buy	193 +53	+38%	+$2.67K	﹤0.01%	364
2018 Q1	$6K	Buy	140 +79	+130%	+$3.68K	﹤0.01%	392
2017 Q4	$3K	Buy	+61	New	+$2.82K	﹤0.01%	446

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lenox Wealth Management's GSK Position: Q2 2020 in Review

Lenox Wealth Management held its GSK (GSK) position steady in Q2 2020 at 52 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #640.

Lenox Wealth Management first reported a position in GSK in Q4 2017 and has held it in 11 quarters since. The position peaked at $18K in Q3 2018. 840 funds tracked by Wall St. Rank hold GSK as of Q2 2020.

Lenox Wealth Management held 52 shares of GSK worth $2K as of Q2 2020.
Lenox Wealth Management left its GSK share count unchanged in Q2 2020.
GSK made up ﹤0.01% of Lenox Wealth Management's portfolio in Q2 2020, its #640 holding.
Lenox Wealth Management first reported a position in GSK in Q4 2017 and has held it in 11 quarters since.
Lenox Wealth Management's GSK position peaked at $18K in Q3 2018.
840 funds tracked by Wall St. Rank held GSK as of Q2 2020.

Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.